REAL WORLD EVIDENCE

Stronger evidence
Smarter access
Faster outcomes

Leverage regulatory-grade and payer-grade RWE to uncover the true effectiveness, safety, and value of your pharmaceutical products – supporting faster approvals, enhanced patient access, and stronger commercial outcomes.

Real-World Evidence 

Real-World Impact

As regulatory bodies increasingly expect RWE to complement clinical trial data, its strategic role in drug development, market access, and reimbursement continues to grow.

athagoras delivers end-to-end RWE solutions – from ethical approvals and EU-wide study coordination to data access, feasibility assessment, and AI-enabled data visualisation.

Our teams combine causal inference, target trial emulation, and predictive modeling to generate real-world data that meets regulatory and payer-grade standards.


Whether enhancing external control arms, informing pricing negotiations, or improving internal decision-making, we turn real world-data into strategic insights and evidence for regulatory applications, market access & reimbursment, internal decision-making, and beyond.

Our solutions

Proven insights.
Stronger access.

Real World Evidence Study Design & Execution

Real-world insights that drive real-world impact

Designing and executing effective RWE studies is key to demonstrating the true value of your pharmaceutical product in everyday clinical settings. athagoras helps you plan and implement rigorous research using real-world data – through cohort studies, pragmatic trials, observational research, and registries.

These studies generate actionable evidence on effectiveness, safety, and value – supporting regulatory submissions, payer decisions, and post-market monitoring. With tailored methodologies and deep industry expertise, we turn real-world insights into strategic advantages for market access and beyond.

  • RWE study design (ENCePP Safety Studies, Comparative 
Effectiveness, Burden of Illness & Unmet Need)
  • RWE study execution
  • Selected CRO services

Evidence Review & Synthesis

Stronger narratives. Smarter decisions.

In a complex and fast-developing data landscape, robust evidence synthesis is essential to demonstrate the full value of your pharmaceutical products. With an ever-growing volume of literature, even experts can’t keep up – athagoras leverages systematic literature reviews and AI-enabled living reviews to surface the latest insights, identify evidence gaps, and maintain a current understanding of the scientific landscape.

We integrate data from clinical trials, real-world studies, and observational research to close evidence gaps and build a cohesive, credible story around your product’s current understanding of the scientific landscape

Whether you’re supporting HTA and reimbursement submissions, regulatory review, or broader value demonstration strategies, our evidence synthesis helps you make informed decisions and gain a competitive edge.

  • Biostatistic services with advanced statistical modeling and AI driven insights
  • Post-hoc clinical trial analysis
  • Systematic and living literature reviews
  • Network meta-analysis
  • Indirect treatment comparison
  • Evidence quality assessment
QUANTIFY RESEARCH is the Nordic market leader in Real-World Evidence and Market Access, delivering expert services in value strategy, modeling, reimbursement support, evidence generation, biostatistics, study design, and analysis.
IGES brings deep local expertise across seven European countries and the UK, offering end-to-end launch support for pharma and medtech. With over 40 years of experience and a team of 200+ experts, IGES delivers best-in-class research and consulting services to drive successful market access.

Contact Us

Let’s move life sciences forward – together

End-to-end support, 

wherever your project starts